Laser Capture Microdissection Market Size, Share & Trends Analysis Report, By Type (Consumables, Software), By Application (Research & Development, Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Laser Capture Microdissection Market Trends

The global laser capture microdissection market size was estimated at USD 189.3 million in 2023 and is expected to grow at a CAGR of 8.37% from 2024 to 2030. The increasing demand for precision medicine, rising cancer incidences, and increasing adoption of clinical diagnostics are anticipated to impel the market growth. Moreover, the growing number of research institutions and advancements in molecular biology are a few other factors that are driving the market.

The COVID-19 pandemic has had a significant impact on the laser capture microdissection (LCM) market. The increased focus on understanding and combating the virus has led to a surge in research activities, including studies on virus mechanisms and the development of diagnostic tools, which has driven demand for advanced technologies like LCM. Additionally, the pandemic accelerated the adoption of precision medicine and advanced diagnostics, as researchers and healthcare professionals sought more detailed and accurate analytical tools.

The rising incidence of cancer worldwide has significantly increased the demand for advanced technologies like laser capture microdissection (LCM). Cancer is a highly heterogeneous disease, meaning that tumors can consist of multiple cell types with distinct genetic and molecular profiles. This heterogeneity makes it challenging to understand the disease's progression and to develop effective treatments. LCM provides a powerful solution by enabling researchers to isolate specific cells or microscopic regions from complex, heterogeneous tissue samples. Thus, the growing cancer cases are anticipated to propel the demand for laser capture microdissection market over the forecast period.

However, new and alternative technologies, such as single-cell sequencing and microfluidics, are also gaining traction. These technologies offer different approaches to cell isolation and analysis, sometimes at a lower cost or with less technical complexity, which can compete with LCM and affect its market growth​. Furthermore, LCM is primarily used in niche research areas such as molecular biology, oncology, and forensic science. The specificity of these applications limits the broader market appeal of LCM, which impacts overall market revenue.

In addition, high research and development expenditure in life sciences, especially in cancer research, genomics, and personalized medicine, drives the demand for LCM technology. Significant investment in these areas requires precise cellular analysis to understand disease mechanisms, identify genetic mutations, and develop targeted therapies. LCM's ability to provide detailed, high-precision data makes it essential for advanced research, fueling its market growth as R&D spending continues to rise.

Market Concentration & Characteristics

The market growth stage is medium, and the pace is accelerating. The increasing demand for precise cellular analysis in fields like cancer research, genomics, and personalized medicine, combined with rising investments in R&D, is driving this acceleration. As more researchers and clinical labs adopt LCM technology for its accuracy and detailed molecular insights, the market is experiencing faster growth.

In the market, the expansion activities are low to moderate owing to the high costs associated with the technology, including the substantial investment required for equipment and consumables. Additionally, the complexity of the technology necessitates specialized training and expertise, which can limit widespread adoption.

There is a significant impact of regulations on the market due to specific requirements, especially those used in clinical diagnostics, must comply with strict guidelines set by regulatory bodies like the FDA and EMA. These regulations ensure the safety, quality, and effectiveness of the devices, which can boost market trust and adoption.

The market currently exhibits a moderate level of product expansion. While there are ongoing advancements in LCM technologies, such as improved precision and integration with other molecular analysis tools, the pace of introducing new products is steady rather than rapid.

The market currently demonstrates a moderate level of regional expansion. While there is steady growth in key markets such as North America and Europe, expansion into emerging regions like Asia-Pacific, Latin America, and the Middle East is progressing at a moderate pace. This is attributed by increasing investment in biomedical research and rising demand for advanced diagnostic tools in these regions. However, factors such as varying regulatory standards, limited awareness, and differences in healthcare infrastructure slow down more rapid regional market penetration.

Type Insights

The consumables segment accounted for the largest revenue share of 32.66% in 2023. This is attributed to the recurring need for consumables such as caps, slides, reagents, and other materials essential for each LCM procedure. Unlike LCM instruments, which are one-time investments, consumables are required continuously, driving steady and significant revenue generation. The frequent use of these consumables in various research applications, including cancer studies, genomics, and proteomics, further boosts the demand and market share of the segment.

The software segment is projected to witness the fastest CAGR of 10.67% over the forecast period owing to the increasing need for advanced data analysis, image processing, and automation in LCM. Thereby, propelling the demand for LCM software for a more integrated research study with other molecular biology tools, and is anticipated to propel over the forecast period.

End-use Insights

The academic & research institutes segment dominated the market and accounted for the largest revenue share of 46.85% in 2023. This is attributed to the extensive use of LCM technologies in academic and research settings for studying complex biological processes, and disease mechanisms, and developing new treatments. Research institutions invest significantly in LCM to support a wide range of applications, including cancer research, genomics, and proteomics. European research programs, like Horizon 2020, have made developing LCM technologies a top priority to boost biomedical research across Europe.

The pharmaceutical & biotech companies segment is expected to witness the fastest growth from 2024 to 2030. This growth is driven by the increasing adoption of laser capture microdissection (LCM) technologies for drug development, biomarker discovery, and precision medicine. Pharmaceutical and biotech firms are leveraging LCM to obtain detailed cellular insights, understand disease mechanisms, and develop targeted therapies more effectively. Thus, anticipated to propel the demand for LCM in pharmaceutical companies and boosting the growth of the segment.

Application Insights

The research & development segment accounted for the largest revenue share of 38.07% in 2023 and is anticipated to grow at the fastest CAGR from 2024 to 2030. This growth is driven by the increasing use of LCM in various research fields, such as cancer research, genomics, proteomics, and personalized medicine. The demand for precise cellular analysis to understand disease mechanisms and develop targeted therapies continues to rise, fueling the adoption of LCM technologies in R&D settings.

According to a research study, published in May 2024, aims to use laser capture microdissection to analyze how T cells interact with lung cancer cells. By isolating these cells from tissue samples, the research seeks to uncover insights that could lead to new treatment approaches or diagnostic tools for lung cancer. In addition, substantial funding and investments in biomedical research further boost the expansion of the R&D segment, making it the fastest-growing application area in the LCM market.

The diagnostic segment is expected to witness significant growth from 2024 to 2030. This anticipated growth is driven by the increasing application of LCM in clinical diagnostics, where precise cellular analysis is crucial for accurate disease diagnosis and personalized treatment plans. Additionally, advancements in technology and growing awareness of the benefits of LCM in clinical settings are further contributing to the segment’s growth over the forecast period.

Regional Insights

North America laser capture microdissection market has dominated the global market with a share of 36.11% in 2023. This attributed to advanced healthcare infrastructure, substantial investment in research and development (R&D), and the presence of key market players. Furthermore, the strong focus on cancer research, genomics, and personalized medicine, coupled with the rising prevalence of cancer and other chronic diseases, is further driving the demand for precise cellular analysis tools like LCM. Thereby, propelling the demand for laser capture microdissection market in the region over the forecast period.

U.S. Laser Capture Microdissection Market Trends

The laser capture microdissection market in the U.S. is expected to grow over the forecast period. This is attributed due to the advanced healthcare infrastructure, robust investment in biomedical research, and increasing adoption of LCM technologies in academic research, clinical diagnostics, and pharmaceutical development.

Europe Laser Capture Microdissection Market Trends

The Europe laser capture microdissection market is experiencing significant growth, driven by increasing investments in cancer research and personalized medicine, coupled with advancements in biotechnology.

The laser capture microdissection market in the UK is expected to grow over the forecast period. In August 2024, twenty-three companies would be receiving a portion of USD 13.30 million (£12 million) from the Innovate UK Cancer Therapeutics program. This program aims to advance new cancer treatments, including immunotherapies and vaccines, and to address gaps in treatments for childhood and young adult cancers.

France laser capture microdissection market is expected to grow over the forecast period due to rising investments in biomedical research and increasing focus on advanced cancer diagnostics and personalized medicine.

The laser capture microdissection market in Germany is expected to grow over the forecast period. Germany's strong focus on advancing cancer research, genomics, and personalized medicine supports the adoption of LCM technologies.

Asia Pacific Laser Capture Microdissection Market Trends

Asia Pacific laser capture microdissection marketis anticipated to grow at the fastest rate of 10.44% over the forecast period. This is attributed to increasing investments in healthcare infrastructure, expanding research capabilities, and rising demand for advanced diagnostic technologies. Furthermore, the rise in academic and research institutions across Asia-Pacific further contributes to the region's dynamic growth in the LCM market.

The laser capture microdissection market in China is expected to grow over the forecast period driven by increasing investments in healthcare and biomedical research. China's expanding focus on advancing cancer research, genomics, and personalized medicine is fueling the demand for LCM technologies.

Japan laser capture microdissection market is expected to grow over the forecast period. The presence of leading research institutions and biotechnology companies, along with government initiatives to promote scientific innovation, is anticipated to contribute to market growth.

The laser capture microdissection market in India is expected to grow over the forecast period, driven by increasing investments in healthcare and research infrastructure. India's expanding focus on advancing cancer research, genomics, and personalized medicine is spurring demand for LCM technologies.

Middle East & Africa Laser Capture Microdissection Market Trends

The Middle East & Africa laser capture microdissection market is expected to experience substantial growth from 2024 to 2030 due to several key factors. Increasing investments in healthcare infrastructure and research facilities across the region are driving demand for advanced diagnostic technologies.

The laser capture microdissection market in Saudi Arabia is expected to grow over the forecast period. The expansion of academic and research institutions in Saudi Arabia is contributing to the growing adoption of LCM solutions in both research and clinical settings.

Kuwait laser capture microdissection market is expected to grow over the forecast period. The rising emphasis on adopting advanced diagnostic tools and enhancing precision medicine in Kuwait is likely to drive the expansion of the LCM market in the region.

Key Laser Capture Microdissection Company Insights

The market players are adopting product approval to increase the reach of their products in the market and improve the availability of their products in diverse geographical areas, along with expansion as a strategy to enhance production/research activities. In addition, several market players are acquiring smaller players to strengthen their market position. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies.

Recent Developments

• In December 2023, Danaher Corporation acquired Abcam plc. Abcam will continue to operate as an independent brand within Danaher's Life Sciences division, which also includes laser capture microdissection devices. This acquisition supports Danaher's strategy to use its technology to better understand complex diseases and speed up drug discovery.

• In November 2023, Laxco announced the launch of the Accuva Cellect Laser Capture Microdissection (LCM) system. This system is anticipated to enable accurate isolation along with capturing cells at individual levels, thus providing an unparalleled precision for elevating research analysis.

• In March 2020, Fluidigm Corporation announced the launch of the AccuLift Laser Capture Microdissection System, a new product portfolio designed for translational and clinical pathology research. The AccuLift system is anticipated to enable precise and efficient capture of individual cells or larger tissue regions for DNA, RNA, and protein biomarker analysis

Laser Capture Microdissection Market Report Scope

Global Laser Capture Microdissection Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global laser capture microdissection market report based on type, application, end-use, and region.

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments

    • Ultraviolet LCM

    • Infrared LCM

    • Ultraviolet & Infrared LCM

    • Immunofluorescence LCM

  • Consumables

    • Reagents & Media

    • Assay Kits

    • Others

  • Software

  • Services

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Research & Development

    • Molecular Biology

    • Cell Biology

    • Forensic Science

  • Diagnostics

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Academic & Research Institute

  • Hospitals

  • Pharmaceutical & Biotech Companies

  • CROs

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait